CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) has been assigned an average rating of “Moderate Buy” from the eight ratings firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month price objective among […]
Shares of CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 […]
CTI BioPharma (NASDAQ:CTIC – Get Rating) had its price objective lowered by TD Cowen from $10.00 to $8.00 in a research note released on Monday, Benzinga reports. The firm currently has an outperform rating on the biopharmaceutical company’s stock. A number of other brokerages have also weighed in on CTIC. StockNews.com raised CTI BioPharma from […]
Needham & Company LLC restated their buy rating on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research note released on Wednesday morning, Benzinga reports. They currently have a $9.00 target price on the biopharmaceutical company’s stock. Several other research analysts also recently commented on CTIC. TD Cowen decreased their price objective on […]
Shares of CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) traded up 4.2% during trading on Thursday . The company traded as high as $4.25 and last traded at $4.25. 934,835 shares were traded during mid-day trading, a decline of 68% from the average session volume of 2,954,565 shares. The stock had previously closed at $4.08. […]